Fact Meets Function

Senescence-associated metabolic alterations aggravate calcific aortic valve disease.

A new study in European Heart Journal shows that declining NAD+ levels with age contribute to calcific aortic valve disease by disrupting cellular metabolism and promoting inflammation. This research provides mechanistic support for NAD+ supplementation in cardiovascular aging, directly validating the therapeutic rationale for NMN. The findings suggest NAD+ restoration could help prevent or slow progression of this common age-related heart condition that currently lacks effective drug treatments.

Senescence-associated metabolic alterations aggravate calcific aortic valve disease. Read Post »

The NAD-brain pharmacokinetic study of NAD augmentation in blood and brain using oral precursor supplementation.

A phase I clinical trial found that oral NMN supplementation at 1,200 mg/day effectively increases NAD levels in both blood and brain tissue, with benefits requiring 2-4 weeks of sustained administration. The study showed once-daily dosing is sufficient and works equally well in healthy individuals and Parkinson’s patients. This provides clinical validation for NMN’s bioavailability and establishes evidence-based dosing protocols that practitioners can reference when prescribing Annular’s NMN product.

The NAD-brain pharmacokinetic study of NAD augmentation in blood and brain using oral precursor supplementation. Read Post »

[Pharmacological Activation of ERRα/β/γ as an Exercise Mimetic: Potential Therapeutic Applications].

This research review examines how activating estrogen-related receptors (ERRα/β/γ) can mimic the beneficial effects of physical exercise at the molecular level. The study focuses on SLU-PP-332, a compound that targets these receptors to potentially provide exercise-like metabolic benefits for patients who cannot engage in regular physical activity. This pharmacological approach could help address chronic diseases linked to sedentary lifestyles by activating the same cellular pathways that exercise normally triggers. The research suggests promise for treating metabolic dysfunction in physically inactive patients.

[Pharmacological Activation of ERRα/β/γ as an Exercise Mimetic: Potential Therapeutic Applications]. Read Post »

BPC157 drives angiogenesis through FBXO22-dependent stabilization of BACH1.

New research identifies the specific molecular pathway BPC-157 uses to promote blood vessel formation – it works by stabilizing BACH1 protein through FBXO22 regulation. This breakthrough helps explain BPC-157’s proven regenerative effects across multiple organ systems and addresses the key scientific gap that has limited its clinical adoption. The research validates BPC-157’s angiogenic properties with concrete mechanistic evidence, strengthening the scientific foundation for practitioner use.

BPC157 drives angiogenesis through FBXO22-dependent stabilization of BACH1. Read Post »

An injectable hydroxyapatite microsphere filler loaded with GHK-Cu tripeptide for anti-Inflammatory and antioxidant.

Researchers developed an injectable filler composed of hydroxyapatite microspheres loaded with GHK-Cu tripeptide and evaluated its anti-inflammatory and antioxidant properties in laboratory conditions. The formulation was tested using in vitro cell culture models to assess its biological activity. This is in vitro research, representing early-stage evidence that precedes animal and human clinical testing.

An injectable hydroxyapatite microsphere filler loaded with GHK-Cu tripeptide for anti-Inflammatory and antioxidant. Read Post »

Protective effect of nicotinamide mononucleotide against soybean isoflavone induced damage in mouse testis.

This animal model study investigated whether nicotinamide mononucleotide (NMN) could protect mouse testis tissue from damage induced by soybean isoflavones, examining potential mechanisms of cellular protection. The researchers found that NMN treatment provided protective effects against the testicular damage caused by isoflavone exposure in mice. This evidence is derived from an animal model study and therefore has limited direct applicability to human populations.

Protective effect of nicotinamide mononucleotide against soybean isoflavone induced damage in mouse testis. Read Post »

Stable Gastric Pentadecapeptide BPC 157 as a Therapy and Safety Key: A Special Beneficial Pleiotropic Effect Controlling and Modulating Angiogenesis and the NO-System.

This in vitro study examined how the gastric pentadecapeptide BPC 157 affects angiogenesis (blood vessel formation) and nitric oxide (NO) system function. The research found that BPC 157 demonstrated pleiotropic effects that could modulate both angiogenesis and NO-dependent vascular processes, suggesting multiple potential mechanisms of action at the cellular level. This is an in vitro study, representing basic laboratory research without human or animal testing.

Stable Gastric Pentadecapeptide BPC 157 as a Therapy and Safety Key: A Special Beneficial Pleiotropic Effect Controlling and Modulating Angiogenesis and the NO-System. Read Post »

Methylene Blue Protects Spatial Working Memory after Traumatic Brain Injury in Mice by Affecting Mitochondrial Quality Control System.

This animal model study investigated how methylene blue affects spatial working memory recovery in mice following traumatic brain injury, finding that the compound protected memory function by modulating the mitochondrial quality control system (including autophagy and mitophagy pathways). Researchers observed that methylene blue treatment improved performance on spatial working memory tasks and influenced key markers of mitochondrial homeostasis in brain tissue after injury. The evidence is from an animal model (mouse) study and does not establish effects in human patients.

Methylene Blue Protects Spatial Working Memory after Traumatic Brain Injury in Mice by Affecting Mitochondrial Quality Control System. Read Post »

Copper Complexes with New Glycyl-l-histidyl-l-lysine-Hyaluronan Conjugates Show Antioxidant Properties and Osteogenic and Angiogenic Synergistic Effects.

This in vitro study investigated copper complexes formed with hyaluronan conjugates of the peptide GHK (glycyl-L-histidyl-L-lysine) to evaluate their antioxidant, osteogenic, and angiogenic properties. The researchers found that these copper-peptide-hyaluronan conjugates demonstrated antioxidant activity and synergistic effects promoting both bone cell differentiation and blood vessel formation in cell culture models. This is an in vitro study and does not represent clinical evidence in human subjects.

Copper Complexes with New Glycyl-l-histidyl-l-lysine-Hyaluronan Conjugates Show Antioxidant Properties and Osteogenic and Angiogenic Synergistic Effects. Read Post »

Protective Effects of BPC 157 on Liver, Kidney, and Lung Distant Organ Damage in Rats with Experimental Lower-Extremity Ischemia-Reperfusion Injury.

This animal model study investigated whether BPC 157, a synthetic peptide, could protect against organ damage in distant organs (liver, kidney, and lung) following lower-extremity ischemia-reperfusion injury in rats. The researchers found that BPC 157 treatment reduced markers of organ damage and inflammatory responses in these distant organs compared to untreated controls. This is an animal model study with no direct human clinical evidence.

Protective Effects of BPC 157 on Liver, Kidney, and Lung Distant Organ Damage in Rats with Experimental Lower-Extremity Ischemia-Reperfusion Injury. Read Post »

Exosome-mediated dual drug delivery of curcumin and methylene blue for enhanced cognitive function and mechanistic elucidation in Alzheimer’s disease therapy.

Researchers investigated exosome-based nanoparticles loaded with both curcumin and methylene blue as a dual drug delivery system for Alzheimer’s disease in an animal model, evaluating effects on cognitive function and underlying mechanisms. The study found that this exosome delivery approach enhanced cognitive outcomes compared to individual drugs or unloaded exosomes, with mechanistic analysis suggesting improvements in oxidative stress reduction and neuroinflammation. **Evidence level: Animal model**

Exosome-mediated dual drug delivery of curcumin and methylene blue for enhanced cognitive function and mechanistic elucidation in Alzheimer’s disease therapy. Read Post »

Intranasal methylene blue administration confers neuroprotection in rats subjected to exhaustive exercise training.

This animal model study investigated whether intranasal methylene blue administration could protect against neurological damage in rats subjected to exhaustive exercise training. Researchers found that methylene blue treatment conferred neuroprotective effects in the studied rats, suggesting potential mechanisms for mitigating exercise-induced neural stress. This evidence is from an animal model and would require further human clinical investigation before application to human populations.

Intranasal methylene blue administration confers neuroprotection in rats subjected to exhaustive exercise training. Read Post »

Scroll to Top